FGF19 and cholestasis: Studies in TPN-fed neonatal piglets showed that the suppression of biliary flow leads to reduced circulating FGF19 and that enteral administration of the bile acid, chenodeoxycholic acid, a potent FXR agonist, increased plasma FGF19 and prevented cholestasis.